These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 38945959)

  • 21. Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine.
    Qu S; Xu R; Yi G; Li Z; Zhang H; Qi S; Huang G
    Mol Biomed; 2024 Feb; 5(1):6. PubMed ID: 38342791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The promises and challenges of patient-derived tumor organoids in drug development and precision oncology.
    Granat LM; Kambhampati O; Klosek S; Niedzwecki B; Parsa K; Zhang D
    Animal Model Exp Med; 2019 Sep; 2(3):150-161. PubMed ID: 31773090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer organoid co-culture model system: Novel approach to guide precision medicine.
    Yuan J; Li X; Yu S
    Front Immunol; 2022; 13():1061388. PubMed ID: 36713421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine.
    Praharaj PP; Bhutia SK; Nagrath S; Bitting RL; Deep G
    Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):117-127. PubMed ID: 29360544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring Tumor-Immune Interactions in Co-Culture Models of T Cells and Tumor Organoids Derived from Patients.
    Jeong SR; Kang M
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient-derived organoids as a model for tumor research.
    Wang J; Feng X; Li Z; Chen Y; Huang W
    Prog Mol Biol Transl Sci; 2022; 189(1):259-326. PubMed ID: 35595351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids.
    Charpentier M; Bloy N; Formenti SC; Galluzzi L; Demaria S
    J Vis Exp; 2024 Apr; (206):. PubMed ID: 38647326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Organoids: approaches and utility in cancer research.
    Zhou B; Feng Z; Xu J; Xie J
    Chin Med J (Engl); 2023 Aug; 136(15):1783-1793. PubMed ID: 37365679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The landscape of drug sensitivity and resistance in sarcoma.
    Al Shihabi A; Tebon PJ; Nguyen HTL; Chantharasamee J; Sartini S; Davarifar A; Jensen AY; Diaz-Infante M; Cox H; Gonzalez AE; Norris S; Sperry J; Nakashima J; Tavanaie N; Winata H; Fitz-Gibbon ST; Yamaguchi TN; Jeong JH; Dry S; Singh AS; Chmielowski B; Crompton JG; Kalbasi AK; Eilber FC; Hornicek F; Bernthal NM; Nelson SD; Boutros PC; Federman NC; Yanagawa J; Soragni A
    Cell Stem Cell; 2024 Oct; 31(10):1524-1542.e4. PubMed ID: 39305899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A systematic review of patient-derived tumor organoids generation from malignant effusions.
    Seghers S; Le Compte M; Hendriks JMH; Van Schil P; Janssens A; Wener R; Komen N; Prenen H; Deben C
    Crit Rev Oncol Hematol; 2024 Mar; 195():104285. PubMed ID: 38311013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Organoid technology in cancer precision medicine.
    Xia X; Li F; He J; Aji R; Gao D
    Cancer Lett; 2019 Aug; 457():20-27. PubMed ID: 31078736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative analysis of response to treatments and molecular features of tumor-derived organoids versus cell lines and PDX derived from the same ovarian clear cell carcinoma.
    Thorel L; Morice PM; Paysant H; Florent R; Babin G; Thomine C; Perréard M; Abeilard E; Giffard F; Brotin E; Denoyelle C; Villenet C; Sebda S; Briand M; Joly F; Dolivet E; Goux D; Blanc-Fournier C; Jeanne C; Villedieu M; Meryet-Figuiere M; Figeac M; Poulain L; Weiswald LB
    J Exp Clin Cancer Res; 2023 Oct; 42(1):260. PubMed ID: 37803448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor organoids: applications in cancer modeling and potentials in precision medicine.
    Xu H; Jiao D; Liu A; Wu K
    J Hematol Oncol; 2022 May; 15(1):58. PubMed ID: 35551634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reconstructing the tumor architecture into organoids.
    Luo Z; Zhou X; Mandal K; He N; Wennerberg W; Qu M; Jiang X; Sun W; Khademhosseini A
    Adv Drug Deliv Rev; 2021 Sep; 176():113839. PubMed ID: 34153370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Organoid Cultures Derived From Patients With Papillary Thyroid Cancer.
    Chen D; Tan Y; Li Z; Li W; Yu L; Chen W; Liu Y; Liu L; Guo L; Huang W; Zhao Y
    J Clin Endocrinol Metab; 2021 Apr; 106(5):1410-1426. PubMed ID: 33524147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Converging bioprinting and organoids to better recapitulate the tumor microenvironment.
    Wang X; Luo Y; Ma Y; Wang P; Yao R
    Trends Biotechnol; 2024 May; 42(5):648-663. PubMed ID: 38071145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of a Novel EUS-FNB-Derived Organoid Co-Culture System for Drug Screening in Patients with Pancreatic Cancer.
    Grützmeier SE; Kovacevic B; Vilmann P; Rift CV; Melchior LC; Holmström MO; Brink L; Hassan H; Karstensen JG; Grossjohann H; Chiranth D; Toxværd A; Hansen CP; Høgdall E; Hasselby JP; Klausen P
    Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complex in vitro 3D models of digestive system tumors to advance precision medicine and drug testing: Progress, challenges, and trends.
    Song SL; Li B; Carvalho MR; Wang HJ; Mao DL; Wei JT; Chen W; Weng ZH; Chen YC; Deng CX; Reis RL; Oliveira JM; He YL; Yan LP; Zhang CH
    Pharmacol Ther; 2022 Nov; 239():108276. PubMed ID: 36055421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Next-Generation Preclinical Functional Testing Models in Cancer Precision Medicine: CTC-Derived Organoids.
    Huang L; Xu Y; Wang N; Yi K; Xi X; Si H; Zhang Q; Xiang M; Rong Y; Yuan Y; Wang F
    Small Methods; 2024 Jan; 8(1):e2301009. PubMed ID: 37882328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient-derived cancer organoids for drug screening: Basic technology and clinical application.
    Ren X; Chen W; Yang Q; Li X; Xu L
    J Gastroenterol Hepatol; 2022 Aug; 37(8):1446-1454. PubMed ID: 35771719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.